Skip to main content

Advertisement

Articles

Page 32 of 35

  1. Lower extremity complications (neuropathy, ulceration, infection, and peripheral arterial disease) are common in diabetes mellitus. There is an inverse relation between plasma testosterone and insulin sensitiv...

    Authors: Svetlana Kalinchenko, Alexandr Zemlyanoy and Louis J Gooren

    Citation: Cardiovascular Diabetology 2009 8:19

    Content type: Case Report

    Published on:

  2. Diabetic cardiomyopathy (DCM) contributes to cardiac failure in diabetic patients. It is characterized by excessive lipids accumulation, with increased triacylglycerol (TAG) stores, and fibrosis in left ventri...

    Authors: Fabien Forcheron, Alexandra Basset, Pauline Abdallah, Peggy Del Carmine, Nicolas Gadot and Michel Beylot

    Citation: Cardiovascular Diabetology 2009 8:16

    Content type: Original investigation

    Published on:

  3. Both insulin and thiazolidinediones (TZDs) are effective in the treatment of hyperglycaemia and amelioration of insulin resistance in type 2 diabetes but have side effects including weight gain and fluid reten...

    Authors: Mozhgan Dorkhan, Magnus Dencker, Martin Stagmo and Leif Groop

    Citation: Cardiovascular Diabetology 2009 8:15

    Content type: Original investigation

    Published on:

  4. Angiotensin converting enzyme (ACE) is a possible candidate gene that may influence both body fatness and blood pressure. Although several genetic studies have been conducted in adults, relatively few studies ...

    Authors: Joey C Eisenmann, Mark A Sarzynski, Kim Glenn, Max Rothschild and Kate A Heelan

    Citation: Cardiovascular Diabetology 2009 8:14

    Content type: Original investigation

    Published on:

  5. Obesity is a major risk factor for development and progression of hypertension and diabetes, which often coexist in obese patients. Losing weight by means of energy restriction and physical activity has been e...

    Authors: Guixiang Zhao, Earl S Ford, Chaoyang Li and Ali H Mokdad

    Citation: Cardiovascular Diabetology 2009 8:13

    Content type: Original investigation

    Published on:

  6. Poor control of type 2 diabetes results in substantial long-term consequences. Studies of new diabetes treatments are rarely designed to assess mortality, complication rates and costs. We sought to estimate th...

    Authors: Sean D Sullivan, Rafael Alfonso-Cristancho, Chris Conner, Mette Hammer and Lawrence Blonde

    Citation: Cardiovascular Diabetology 2009 8:12

    Content type: Original investigation

    Published on:

  7. The renin-angiotensin aldosterone system (RAAS) plays an important role in regulating the blood pressure and the genetic polymorphisms of RAAS genes has been extensively studied in relation to the cardiovascul...

    Authors: Vasudevan Ramachandran, Patimah Ismail, Johnson Stanslas and Norashikin Shamsudin

    Citation: Cardiovascular Diabetology 2009 8:11

    Content type: Original investigation

    Published on:

  8. Inflammation contributes to cardiovascular complications in type 2 diabetes, which are often characterized by microvascular alterations. We investigated whether myeloid-related protein 8/14 complex (MRP8/14) s...

    Authors: Klaus Burkhardt, Sonja Schwarz, Chengrui Pan, Felix Stelter, Konstantin Kotliar, Maxilian Von Eynatten, Daniel Sollinger, Ines Lanzl, Uwe Heemann and Marcus Baumann

    Citation: Cardiovascular Diabetology 2009 8:10

    Content type: Original investigation

    Published on:

  9. Insulin glargine (glargine) and premixed insulins (premix) are alternative insulin treatments. This analysis evaluated glycaemic control in 528 patients with type 1 (n = 183) or type 2 (n = 345) diabetes, afte...

    Authors: Peter Sharplin, Jason Gordon, John R Peters, Anthony P Tetlow, Andrea J Longman and Philip McEwan

    Citation: Cardiovascular Diabetology 2009 8:9

    Content type: Original investigation

    Published on:

  10. High glucose could induce structure and function change in cardiomyocytes, PKC plays a core effect in the onset and progression of diabetic cardiomyopathy, but its underlying downstream signal transduction pat...

    Authors: Wang Min, Zhang Wen Bin, Zhou Bin Quan, Zhu Jun Hui and Fu Guo Sheng

    Citation: Cardiovascular Diabetology 2009 8:8

    Content type: Original investigation

    Published on:

  11. The prevalence of vitamin D insufficiency and secondary hyperparathyroidism is high among morbidly obese subjects. Further, low serum levels of 25-hydroxyvitamin D (25 [OH]D) and magnesium have been associated...

    Authors: Jøran Hjelmesæth, Dag Hofsø, Erlend T Aasheim, Trond Jenssen, Johan Moan, Helle Hager, Jo Røislien and Jens Bollerslev

    Citation: Cardiovascular Diabetology 2009 8:7

    Content type: Original investigation

    Published on:

  12. A high prevalence of impaired glucose tolerance and unknown type 2-diabetes in patients with coronary heart disease and no previous diagnosis of diabetes have been reported. The aims of the present study were ...

    Authors: Eva C Knudsen, Ingebjørg Seljeflot, Michael Abdelnoor, Jan Eritsland, Arild Mangschau, Harald Arnesen and Geir Ø Andersen

    Citation: Cardiovascular Diabetology 2009 8:6

    Content type: Original investigation

    Published on:

  13. The effects of pan-peroxisome proliferator-activated receptor (PPAR) ligand bezafibrate on N-terminal pro-B type natriuretic peptide (ProBNP) level in patients with coronary artery disease (CAD) is unknown. Th...

    Authors: Koichi Node, Teruo Inoue, Valentin Boyko, Ilan Goldberg, Enrique Z Fisman, Yehuda Adler, Ehud Schwammenthal, Zipora Matas, Solomon Behar and Alexander Tenenbaum

    Citation: Cardiovascular Diabetology 2009 8:5

    Content type: Original investigation

    Published on:

  14. Poor control of blood glucose in diabetes is known to promote vascular dysfunction and hypertension. Diabetes was recently shown to be linked to an increased prevalence of pulmonary hypertension. The aim of th...

    Authors: Alison M Gurney and Frank C Howarth

    Citation: Cardiovascular Diabetology 2009 8:4

    Content type: Original investigation

    Published on:

  15. Insulin glargine (glargine) and insulin NPH (NPH) are two basal insulin treatments. This study investigated the effect on glycaemic control of switching from a NPH-based regimen to a glargine-based regimen in ...

    Authors: Peter Sharplin, Jason Gordon, John R Peters, Anthony P Tetlow, Andrea J Longman and Philip McEwan

    Citation: Cardiovascular Diabetology 2009 8:3

    Content type: Original investigation

    Published on:

  16. Differences in prevalence of cardiometabolic risk factors between different ethnic groups are largely unknown. We determined the variation in cardiometabolic risk profile according to ethnicity in a cohort ove...

    Authors: Mariska van Vliet, Inès A von Rosenstiel, Roger K Schindhelm, Desiderius PM Brandjes, Jos H Beijnen and Michaela Diamant

    Citation: Cardiovascular Diabetology 2009 8:2

    Content type: Original investigation

    Published on:

  17. Mixed hyperlipidemia is common in patients with diabetes. Statins, the choice drugs, are effective at reducing lipoproteins that contain apolipoprotein B100, but they fail to exert good control over intestinal...

    Authors: Pedro Valdivielso, José Rioja, Carlota García-Arias, Miguel Angel Sánchez-Chaparro and Pedro González-Santos

    Citation: Cardiovascular Diabetology 2009 8:1

    Content type: Study protocol

    Published on:

  18. The use of abciximab (c7E3 Fab) or eptifibatide improves clinical outcomes in diabetics undergoing percutaneous coronary intervention. These β3 integrin inhibitors antagonize fibrinogen binding to αIIbβ3 integrin...

    Authors: Alokkumar Pathak, Renyi Zhao, Jianhua Huang and George A Stouffer

    Citation: Cardiovascular Diabetology 2008 7:36

    Content type: Original investigation

    Published on:

  19. Several aspects concerning the relationship between the metabolic syndrome and incident diabetes are incompletely understood including the magnitude of the risk estimate, potential gender differences in the as...

    Authors: Earl S Ford, Matthias B Schulze, Tobias Pischon, Manuela M Bergmann, Hans-Georg Joost and Heiner Boeing

    Citation: Cardiovascular Diabetology 2008 7:35

    Content type: Original investigation

    Published on:

  20. Different mechanisms of diabetic-induced NO dysfunction have been proposed and central to most of them are significant changes in eNOS function as the rate-limiting step in NO bioavailability. eNOS exists in b...

    Authors: James Grijalva, Steven Hicks, Xiangmin Zhao, Sushma Medikayala, Pawel M Kaminski, Michael S Wolin and John G Edwards

    Citation: Cardiovascular Diabetology 2008 7:34

    Content type: Original investigation

    Published on:

  21. We investigated the role of polyol pathway enzymes aldose reductase (AR) and sorbitol dehydrogenase (SDH) in mediating injury due to ischemia-reperfusion (IR) in Type 2 diabetic BBZ rat hearts. Specifically, w...

    Authors: Qing Li, Yuying C Hwang, Radha Ananthakrishnan, Peter J Oates, Dennis Guberski and Ravichandran Ramasamy

    Citation: Cardiovascular Diabetology 2008 7:33

    Content type: Original investigation

    Published on:

  22. In Sweden, diabetes prevalence is increasing in spite of unchanged incidence, indicating improved survival. In recent US studies mortality in diabetic subjects has decreased over three decades, but only in men...

    Authors: Mats Eliasson, Mats Talbäck and Måns Rosén

    Citation: Cardiovascular Diabetology 2008 7:32

    Content type: Original investigation

    Published on:

  23. Current guidelines from the European Society of Cardiology (ESC) define low thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol (LDL-C) to guide treatment. Although be...

    Authors: Elisabeth Steinhagen-Thiessen, Peter Bramlage, Christian Lösch, Hans Hauner, Heribert Schunkert, Anja Vogt, Jürgen Wasem, Karl-Heinz Jöckel and Susanne Moebus

    Citation: Cardiovascular Diabetology 2008 7:31

    Content type: Original investigation

    Published on:

  24. Cardiovascular disease is the major cause of morbidity and mortality associated with diabetes. There is increasing evidence that advanced glycation endproducts (AGEs) play a pivotal role in atherosclerosis, in...

    Authors: Robbert Meerwaldt, Thera Links, Clark Zeebregts, Rene Tio, Jan-Luuk Hillebrands and Andries Smit

    Citation: Cardiovascular Diabetology 2008 7:29

    Content type: Review

    Published on:

  25. We examined, in a country of the African region, i) the prevalence of the metabolic syndrome (MetS) according to three definitions (ATP, WHO and IDF); ii) the distribution of the MetS criteria; iii) the level ...

    Authors: Clara Kelliny, Julita William, Walter Riesen, Fred Paccaud and Pascal Bovet

    Citation: Cardiovascular Diabetology 2008 7:27

    Content type: Original investigation

    Published on:

  26. The role of structural and functional abnormalities of small vessels in diabetes cardiomyopathy remains unclear. Myocardial contrast echocardiography allows the quantification of myocardial blood flow at rest ...

    Authors: Bernard Cosyns, Steven Droogmans, Sophie Hernot, Céline Degaillier, Christian Garbar, Caroline Weytjens, Bram Roosens, Danny Schoors, Tony Lahoutte, Philippe R Franken and Guy Van Camp

    Citation: Cardiovascular Diabetology 2008 7:26

    Content type: Original investigation

    Published on:

  27. Anaemia has been shown in previous studies to be a risk factor for cardiovascular disease in diabetic patients with chronic kidney disorder. This study was aimed to assess the prevalence of anaemia and kidney ...

    Authors: Chidum E Ezenwaka, Altheia Jones-LeCointe, Emeka Nwagbara, Dawn Seales and Fidelis Okali

    Citation: Cardiovascular Diabetology 2008 7:25

    Content type: Original investigation

    Published on:

  28. Exenatide belongs to a new therapeutic class in the treatment of diabetes (incretin mimetics), allowing glucose-dependent glycaemic control in Type 2 diabetes. Randomised controlled trial data suggest that exe...

    Authors: Anette Woehl, Mark Evans, Anthony P Tetlow and Philip McEwan

    Citation: Cardiovascular Diabetology 2008 7:24

    Content type: Original investigation

    Published on:

  29. Obesity is a multifactorial disorder, that is, a disease determined by the combined effect of genes and environment. In this context, polygenic approaches are needed.

    Authors: María E Sáez, Antonio Grilo, Francisco J Morón, Luis Manzano, María T Martínez-Larrad, Antonio González-Pérez, Javier Serrano-Hernando, Agustín Ruiz, Reposo Ramírez-Lorca and Manuel Serrano-Ríos

    Citation: Cardiovascular Diabetology 2008 7:23

    Content type: Original investigation

    Published on:

  30. Recent clinical trials reported conflicting results on the reduction of new-onset diabetes using RAS blocking agents. Therefore the role of these agents in preventing diabetes is still not well defined. Ramipr...

    Authors: Walter Zidek, Joachim Schrader, Stephan Lüders, Stephan Matthaei, Christoph Hasslacher, Joachim Hoyer, Peter Bramlage, Claus-Dieter Sturm and W Dieter Paar

    Citation: Cardiovascular Diabetology 2008 7:22

    Content type: Original investigation

    Published on:

  31. There is currently much interest in encouraging individuals to increase physical activity in order to reduce CVD risk. This study has been designed to determine if personalised CVD risk appreciation can increa...

    Authors: Hermione C Price, Lynne Tucker, Simon J Griffin and Rury R Holman

    Citation: Cardiovascular Diabetology 2008 7:21

    Content type: Study protocol

    Published on:

  32. The metabolic deregulation associated with diabetes mellitus (DM) causes secondary pathophysiologic changes in multiple organ systems. Endothelial injury is induced by oxidative stress (OS) and inflammation. W...

    Authors: Raymond Farah, Revital Shurtz-Swirski and Olga Lapin

    Citation: Cardiovascular Diabetology 2008 7:20

    Content type: Original investigation

    Published on:

  33. Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a ce...

    Authors: Alexander Tenenbaum, Valentina Boyko, Enrique Z Fisman, Ilan Goldenberg, Yehuda Adler, Micha S Feinberg, Michael Motro, David Tanne, Joseph Shemesh, Ehud Schwammenthal and Solomon Behar

    Citation: Cardiovascular Diabetology 2008 7:18

    Content type: Original investigation

    Published on:

  34. The large clinical trials proved that Basal-Bolus (BB) insulin therapy was effective in the prevention of diabetic complications and their progression. However, BB therapy needs multiple insulin injections per...

    Authors: Yumi Miyashita, Rimei Nishimura, Masami Nemoto, Toru Matsudaira, Hideaki Kurata, Tamotsu Yokota, Kuninobu Yokota, Katsuyoshi Tojo, Kazunori Utsunomiya and Naoko Tajima

    Citation: Cardiovascular Diabetology 2008 7:16

    Content type: Original investigation

    Published on:

  35. In comparison to the well established changes in compliance that occur at the large vessel level in diabetes, much less is known about the changes in compliance of the cardiovascular system at the end-organ le...

    Authors: Richard J MacIsaac, Merlin C Thomas, Sianna Panagiotopoulos, Trudy J Smith, Huming Hao, D Geoffrey Matthews, George Jerums, Louise M Burrell and Piyush M Srivastava

    Citation: Cardiovascular Diabetology 2008 7:15

    Content type: Original investigation

    Published on:

  36. Epidemiological studies have revealed a relationship between early growth restriction and the subsequent development of insulin resistance and type 2 diabetes. Ligation of the uterine arteries in rats mimics u...

    Authors: Daniela Germani, Antonella Puglianiello and Stefano Cianfarani

    Citation: Cardiovascular Diabetology 2008 7:14

    Content type: Original investigation

    Published on:

  37. Diabetes has negative, and exercise training positive, effects on the skeletal muscle vasculature, but the mechanisms are not yet fully understood. In the present experiment the effects of running exercise on ...

    Authors: Riikka Kivelä, Mika Silvennoinen, Maarit Lehti, Sanni Jalava, Veikko Vihko and Heikki Kainulainen

    Citation: Cardiovascular Diabetology 2008 7:13

    Content type: Original investigation

    Published on:

  38. Hypertension and type 2 diabetes are common co-morbidities. Preliminary studies suggest that thiazolidinediones reduce blood pressure (BP). We therefore used ambulatory BP to quantify BP lowering at 6–12 month...

    Authors: Michel Komajda, Paula Curtis, Markolf Hanefeld, Henning Beck-Nielsen, Stuart J Pocock, Andrew Zambanini, Nigel P Jones, Ramon Gomis and Philip D Home

    Citation: Cardiovascular Diabetology 2008 7:10

    Content type: Original investigation

    Published on:

  39. There are no risk scores available for predicting heart failure in Type 2 diabetes mellitus (T2DM). Based on the Hong Kong Diabetes Registry, this study aimed to develop and validate a risk score for predictin...

    Authors: Xilin Yang, Ronald C Ma, Wing-Yee So, Alice P Kong, Gary T Ko, Chun-Shun Ho, Christopher W Lam, Clive S Cockram, Peter C Tong and Juliana C Chan

    Citation: Cardiovascular Diabetology 2008 7:9

    Content type: Original investigation

    Published on:

  40. An authentic survey of the transcript-level response of the diabetic endothelium in vivo is key to understanding diabetic cardiovascular complications such as accelerated atherosclerosis and endothelial dysfun...

    Authors: J Gregory Maresh and Ralph V Shohet

    Citation: Cardiovascular Diabetology 2008 7:8

    Content type: Original investigation

    Published on:

Annual Journal Metrics

Advertisement